近岸蛋白: 第二届监事会第九次会议决议公告

Core Points - The Supervisory Board of Suzhou Nearshore Protein Technology Co., Ltd. held its ninth meeting of the second session on August 27, 2025, where all resolutions were passed unanimously by the three attending supervisors [1][2][3][4] Group 1: Meeting Overview - The meeting was convened and chaired by Mr. Li Debin, and all procedures complied with relevant laws and regulations [1] - The meeting reviewed and approved the 2025 semi-annual report, confirming that it accurately reflects the company's financial status and operational results [1][2] Group 2: Financial Reports - The Supervisory Board approved the semi-annual fundraising storage and usage report, confirming compliance with relevant regulations and that funds were used appropriately without harming shareholder interests [2][3] - The board also approved the asset impairment provision report, stating that the provision aligns with accounting standards and accurately reflects the company's financial condition [3] Group 3: Fund Utilization - The board reviewed the proposal to use part of the excess raised funds, amounting to 72 million RMB, to permanently supplement working capital, which is expected to enhance operational efficiency and profitability [4] - This proposal was also unanimously approved and will be submitted for consideration at the company's first extraordinary general meeting of 2025 [4]